<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>938</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10520183</PubmedId>
            <Abstract>Cytotoxic T (Tc)-cell responses against influenza virus infection in BALB/c (H-2d) mice are dominated by Tc clones reactive to the viral nucleoprotein (NP). Here, we report investigations using recombinant vaccinia viruses (VV) encoding major histocompatibility complex (MHC) class I H-2Kd molecules differing by a single amino acid from glutamine (wild-type, Kdw) to histidine (mutant, Kdm) at position 114 located in the floor of the peptide-binding groove. Influenza-infected target cells expressing Kdw were strongly lysed by Kd-restricted Tc cells against A/WSN influenza virus or the immunodominant peptide of viral NP (NPP147-155), whereas infected Kdm-expressing targets gave little or no lysis, respectively, thus showing the immunodominance of NPP147-155. Kdm-expressing target cells saturated with synthetic NPP147-155 (10-5 M) were lysed similarly to Kdw-expressing targets by NPP147-155-specific Tc cells. Thus the defect in influenza-infected Kdm-expressing targets was quantitative; insufficient Kdm-peptide complexes were expressed. Tc-cell responses against four other viruses or alloantigens showed no effect of Kdm. When peptide transport-defective cells were infected with VV-Kdw or VV-Kdm and co-infected with a recombinant VV encoding an endoplasmic reticulum-targeted viral peptide, two influenza haemaglutinin peptides caused higher expression of Kdw than NPP147-155 indicating their higher affinity for Kdw. These results are inconsistent with the hypothesis that immunodominance in the anti-influenza response reflects high affinity of the immunodominant peptide, but are consistent with skewing of the Tc-cell receptor repertoire.</Abstract>
            <ArticleYear>1999</ArticleYear>
            <ArticlePages>420-6</ArticlePages>
            <ArticleTitle>High peptide affinity for MHC class I does not correlate with immunodominance.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>MÃ¼llbacher</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Lobigs</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Yewdell</LastName>
                    <ForeName>J W</ForeName>
                </Author>
                <Author>
                    <LastName>Bennink</LastName>
                    <ForeName>J R</ForeName>
                </Author>
                <Author>
                    <LastName>Tha Hla</LastName>
                    <ForeName>R</ForeName>
                </Author>
                <Author>
                    <LastName>Blanden</LastName>
                    <ForeName>R V</ForeName>
                </Author>
            </Authors>
            <Affiliations>Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra, A.C.T. 2601, Australia.</Affiliations>
            <ArticleChemicalList>H-2 Antigens;H-2K(K) antigen;Immunodominant Epitopes;Isoantigens;Nucleoproteins;Peptide Fragments;Recombinant Proteins;nucleoprotein (147-155)</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antigen Presentation; H-2 Antigens(genetics; immunology; metabolism); Immunodominant Epitopes; Influenza A virus(genetics; immunology); Isoantigens; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mutation; Nucleoproteins(immunology; metabolism); Orthomyxoviridae Infections(immunology); Peptide Fragments(immunology; metabolism); Protein Binding; Recombinant Proteins(immunology); T-Lymphocytes, Cytotoxic(immunology); Vaccinia virus(genetics)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>50</Volume>
                <Issue>4</Issue>
                <Title>Scandinavian journal of immunology</Title>
                <Issn>1365-3083</Issn>
                <MedlineTa>Scand J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>NPP 145-155</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TYQRTRALV</LinearSequence>
                        <StartingPosition>147</StartingPosition>
                        <EndingPosition>155</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC124</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Previous references</LocationOfData>
                <EpitopeId>67436</EpitopeId>
                <ReferenceStartingPosition>147</ReferenceStartingPosition>
                <ReferenceEndingPosition>155</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1C</LocationOfData>
                        <TCellId>1274445</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TYQRTRALV</LinearSequence>
                                            <StartingPosition>147</StartingPosition>
                                            <EndingPosition>155</EndingPosition>
                                            <SourceMolecule>
                                                <IedbAccession>SRC124</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NPP 145-155</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>The generation of the anti-eptiope cell line was previously described.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>L cells-Fibroblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Influenza A virus (A/Puerto Rico/8/34(H1N1))</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Wild type Kd-expressing target cells infected Flu are efficiently lysed by NP147-155 specific T cells, while mutant Kd  (where aa141, located at the floor of the peptide binding groove, is changed from Q to H)-expressing cells are not recognized. The same results are seen when target cells are infected with recombinant vaccinia enconding the Flu nucleoprotein. The presentation of epitope in mutant Kb-peptide loaded cells is not affected at high concentrations.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>14950</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Wild type Kd expressing cells are abl[e to bind this immunodominant epitope, while mutant Kd  (where aa141, located at the floor of the peptide binding groove, is changed from Q to H) molecules fail to efficiently present epitope, although other source species peptides are efficiently presented. Since mutant Kd-expressing cells infected with Flu are not lysed by Flu-specific T-cells, the presentation of those other peptides from Flu over the level of immunodominant epitope NP147-155 is not sufficient to change the immunodominance pattern, implying that MHC affinity is not a determinant of  immunodominance.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>124</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

